| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 160,273 | 53,677 | 56,494 | 197,122 | | Cost of Revenue | 119,630 | 39,065 | 40,981 | 147,967 | | | Gross Profit | 40,643 | 14,612 | 15,513 | 49,155 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 26,238 | 21,361 | 22,505 | 22,805 | | Non Recurring |
-
|
-
| 1,413 | (275) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,405 | (6,749) | (8,405) | 26,625 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 138 | 113 | 188 | (225) | | Earnings Before Interest And Taxes | 13,514 | (6,636) | (8,217) | 26,400 | | Interest Expense | (368) | 368 | 258 | 1,093 | | Income Before Tax | 13,882 | (7,004) | (8,475) | 25,307 | | Income Tax Expense | 4,990 | (2,514) | (3,041) | 8,895 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,892 | (4,490) | (5,434) | 16,412 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,892 | (4,490) | (5,434) | 16,412 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,892 | ($4,490) | ($5,434) | $16,412 |
|
0.26% Nasdaq 
Income Statement
